Laboratory analysis may reveal altered liver function tests in the form of elevated hepatic enzymes.
In addition to reducing the expression of transferrin and ceruloplasmin genes, hypolipidemic peroxisome proliferators may alter iron homeostasis in the liver.
These factors may alter insulin responsiveness in fat, liver, muscle, and endothelial function resulting in metabolic syndrome, type 2 diabetes, ED, and CVD.
While limited by the constraints of a cross-sectional design, these results raise the possibility that chronic viral liver disease may alter the pace of MeHg hepatobiliary elimination in reproductive-age women – and therefore also affect the risk of neurotoxicity to the developing fetus.
However, it is possible that nitrate may alter the action of estradiol in the liver.
Adjustment could be appropriate because obesity can affect liver function, and thus may alter phthalate metabolism.
It is well known that general anaesthesia and intraoperative stress can have profound effects on liver metabolism and ultimately may alter hepatic [F]FDG uptake as well [ 34, 35].
Liver damage caused by alcohol consumption and HCV may alter serum levels of inflammatory biomarkers that are synthesized in the liver (e.g., C reactive protein) and possibly confound the association between viremia and biomarkers of systemic inflammation.
Hepatic impairment may alter the pharmacokinetics of drugs that are metabolized by the liver, such as rivaroxaban and apixaban [ 56].
